JP5804592B2 - 抗アレルギーのための医薬品組成物 - Google Patents

抗アレルギーのための医薬品組成物 Download PDF

Info

Publication number
JP5804592B2
JP5804592B2 JP2011096512A JP2011096512A JP5804592B2 JP 5804592 B2 JP5804592 B2 JP 5804592B2 JP 2011096512 A JP2011096512 A JP 2011096512A JP 2011096512 A JP2011096512 A JP 2011096512A JP 5804592 B2 JP5804592 B2 JP 5804592B2
Authority
JP
Japan
Prior art keywords
strawberry
glyceraldehyde
phosphate dehydrogenase
ige antibody
ige
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2011096512A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012229164A (ja
JP2012229164A5 (cg-RX-API-DMAC7.html
Inventor
浩治 川原
浩治 川原
井上　祐一
祐一 井上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of National Colleges of Technologies Japan
Original Assignee
Institute of National Colleges of Technologies Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of National Colleges of Technologies Japan filed Critical Institute of National Colleges of Technologies Japan
Priority to JP2011096512A priority Critical patent/JP5804592B2/ja
Priority to EP12773893.8A priority patent/EP2705851B1/en
Priority to PCT/JP2012/060389 priority patent/WO2012144501A1/ja
Priority to US14/113,198 priority patent/US9511124B2/en
Publication of JP2012229164A publication Critical patent/JP2012229164A/ja
Publication of JP2012229164A5 publication Critical patent/JP2012229164A5/ja
Application granted granted Critical
Publication of JP5804592B2 publication Critical patent/JP5804592B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/01—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
    • C12Y102/01012—Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) (1.2.1.12)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2011096512A 2011-04-22 2011-04-22 抗アレルギーのための医薬品組成物 Expired - Fee Related JP5804592B2 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2011096512A JP5804592B2 (ja) 2011-04-22 2011-04-22 抗アレルギーのための医薬品組成物
EP12773893.8A EP2705851B1 (en) 2011-04-22 2012-04-17 Anti-allergy substance, anti-allergy agent, and food
PCT/JP2012/060389 WO2012144501A1 (ja) 2011-04-22 2012-04-17 抗アレルギー物質、抗アレルギー剤及び食品
US14/113,198 US9511124B2 (en) 2011-04-22 2012-04-17 Anti-allergic substance, anti-allergic agent, and food

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011096512A JP5804592B2 (ja) 2011-04-22 2011-04-22 抗アレルギーのための医薬品組成物

Publications (3)

Publication Number Publication Date
JP2012229164A JP2012229164A (ja) 2012-11-22
JP2012229164A5 JP2012229164A5 (cg-RX-API-DMAC7.html) 2014-05-08
JP5804592B2 true JP5804592B2 (ja) 2015-11-04

Family

ID=47041607

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011096512A Expired - Fee Related JP5804592B2 (ja) 2011-04-22 2011-04-22 抗アレルギーのための医薬品組成物

Country Status (4)

Country Link
US (1) US9511124B2 (cg-RX-API-DMAC7.html)
EP (1) EP2705851B1 (cg-RX-API-DMAC7.html)
JP (1) JP5804592B2 (cg-RX-API-DMAC7.html)
WO (1) WO2012144501A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5757624B2 (ja) * 2011-04-22 2015-07-29 独立行政法人国立高等専門学校機構 抗アレルギー因子のスクリーニング方法
TWI619507B (zh) * 2013-03-22 2018-04-01 東宇生物科技股份有限公司 治療或預防過敏性疾病的有效成分
JP6372844B2 (ja) * 2013-12-04 2018-08-15 株式会社バイオサイエンスリンク グリセルアルデヒド３リン酸脱水素酵素（ｇａｐｄｈ）由来ペプチド及びこれを含む抗アレルギー組成物
CN120187420A (zh) * 2022-11-15 2025-06-20 株式会社日水 用于减轻或预防过敏性鼻炎或过敏性结膜炎的症状的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000139404A (ja) * 1998-03-29 2000-05-23 Nippon Meat Packers Inc 低アレルゲン化食肉製品及びその製造方法
NZ523995A (en) * 2000-08-08 2005-03-24 Genesis Res & Dev Corp Ltd Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
JP5035582B2 (ja) * 2000-08-28 2012-09-26 昭 粟屋 医薬組成物
US6924135B2 (en) * 2003-08-29 2005-08-02 Zeon Corporation DNA encoding Eimeria glyceroaldehyde-3-phosphate dehydrogenase and uses thereof

Also Published As

Publication number Publication date
US9511124B2 (en) 2016-12-06
EP2705851B1 (en) 2016-07-13
US20140037690A1 (en) 2014-02-06
JP2012229164A (ja) 2012-11-22
EP2705851A4 (en) 2014-10-15
WO2012144501A1 (ja) 2012-10-26
EP2705851A1 (en) 2014-03-12

Similar Documents

Publication Publication Date Title
US9481716B2 (en) Treatment for peanut allergy
Huang et al. Myricetin possesses anthelmintic activity and attenuates hepatic fibrosis via modulating TGFβ1 and Akt signaling and shifting Th1/Th2 balance in Schistosoma japonicum-infected mice
Wang et al. Secoisolariciresinol diglucoside suppresses Dextran sulfate sodium salt-induced colitis through inhibiting NLRP1 inflammasome
JP2013512235A (ja) 野菊抽出物またはこの分画物を含む抗炎症活性を持つ組成物
CA3095082A1 (en) Combinations of osteopontin and 2'-fucosyllactose for use as medicaments
JP5804592B2 (ja) 抗アレルギーのための医薬品組成物
Janusz et al. Colostrinin: a proline-rich polypeptide complex of potential therapeutic interest
CN100376255C (zh) 具有抗炎活性和抗动脉粥样硬化活性的藿香提取物以及含有从所述提取物中分离和提纯的椴素的组合物
RU2423139C2 (ru) КОМПОЗИЦИИ, СОДЕРЖАЩИЕ Actinidia, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
KR101217181B1 (ko) 탄닌산 및 퀘르세틴을 유효성분으로 함유하는 아토피성 피부염 예방, 개선 또는 치료용 조성물
US12201664B2 (en) Composition for preventing or treating allergic diseases containing mixed extract of two or more among Asiasarum root, Platycodon root, and Cinnamomi ramulus as active ingredients
KR20130133477A (ko) 상황버섯 추출물의 전립선 비대증 개선, 여드름 개선, 발모 촉진 용도
KR20110126426A (ko) 알레르기 및 대장염증 질환 치료 효능을 가지는 뽕나무 추출물 및 이를 활용한 약학적 조성물 및 기능성 식품 조성물
JP5109113B2 (ja) ＩｇＥ捕捉剤、並びに抗アレルギー性の医薬組成物、化粧料組成物、食料組成物、飲料組成物及び飼料組成物
JP6372844B2 (ja) グリセルアルデヒド３リン酸脱水素酵素（ｇａｐｄｈ）由来ペプチド及びこれを含む抗アレルギー組成物
JP6023398B2 (ja) アズキ由来抗アレルギー剤の製造方法
KR20200099357A (ko) 벚나무 껍질 추출물을 유효성분으로 포함하는 알레르기 질환의 예방 또는 치료용 약학적 조성물
JP2017048161A (ja) レンコン節部の抽出物を含有する抗アレルギー剤
Sosic Development and Evaluation of Novel Approaches in Allergen-Specific Immunotherapy
US11129857B2 (en) Antivenom compositions and uses thereof
KR20190007184A (ko) 산국 에센셜 오일 또는 1-아이오도헥사데칸을 유효성분으로 함유하는 아토피 피부염 개선 또는 피부 장벽 강화용 조성물
Jalandar Clinical Study on Effect of Swarnamritaprashana (Modified Swarna Prashana) on Immunity (IgG) in Toddlers
KR20150022716A (ko) 다우리놀 화합물을 유효성분으로 포함하는 면역질환의 예방 및 치료용 조성물
KR101821118B1 (ko) 감보그 산(gambogic acid)을 포함한 알러지성 질환 예방 또는 치료용 조성물
JP2015010041A (ja) 抗アレルギー剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140318

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140318

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150316

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150515

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150603

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150722

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150812

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150828

R150 Certificate of patent or registration of utility model

Ref document number: 5804592

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees